• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对东亚特发性肺纤维化人群的改良GAP模型。

A modified GAP model for East-Asian populations with idiopathic pulmonary fibrosis.

作者信息

Nishikiori Hirotaka, Chiba Hirofumi, Lee Sang Hoon, Kondoh Shun, Kamo Ken-Ichi, Nakamura Koshi, Ikeda Kimiyuki, Kuronuma Koji, Chung Man Pyo, Kondoh Yasuhiro, Homma Sakae, Inase Naohiko, Park Moo Suk, Takahashi Hiroki

机构信息

Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Japan.

Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Institute of Chest Diseases, Yonsei University College of Medicine, Republic of Korea.

出版信息

Respir Investig. 2020 Sep;58(5):395-402. doi: 10.1016/j.resinv.2020.04.001. Epub 2020 Jul 24.

DOI:10.1016/j.resinv.2020.04.001
PMID:32718834
Abstract

BACKGROUND

The easy-to-calculate gender, age, and lung physiology (GAP) model shows good predictive and discriminative performance in the prognosis of idiopathic pulmonary fibrosis (IPF). However, the GAP model was not effective in predicting the prognosis accurately in previous Japanese and Korean IPF cohort studies. Therefore, we developed a modified GAP model for the East-Asian populations by weighing the GAP variables. The validity of the modified GAP model was subsequently evaluated in East-Asian IPF patients.

METHODS

The derivation cohort comprised 326 patients with IPF. Weights of the variables were adjusted on the basis of coefficients derived from Cox regression models. The total points were distributed to the three stages of the disease so that the number of patients included in each stage was appropriate. The validity of the modified model was analyzed in another Japanese cohort of 117 patients with IPF and a nationwide cohort of Korean patients with IPF.

RESULTS

Predicted survival rates differed significantly in the derivation cohort using the modified GAP model for each stage of IPF (log-rank test: stage I vs. stage II, p < 0.001; stage II vs. stage III, p < 0.001). Model performance improved according to Harrell's C-index (at three years: 0.696 in the original GAP model to 0.738 in the modified model). The performance of the modified model was validated in the Japanese validation and Korean national cohorts.

CONCLUSIONS

Our modification of the original GAP model showed improved performance in East-Asian IPF patient populations.

摘要

背景

易于计算的性别、年龄和肺生理学(GAP)模型在特发性肺纤维化(IPF)的预后评估中显示出良好的预测和判别性能。然而,在先前的日本和韩国IPF队列研究中,GAP模型在准确预测预后方面并不有效。因此,我们通过对GAP变量进行加权,为东亚人群开发了一种改良的GAP模型。随后在东亚IPF患者中评估了改良GAP模型的有效性。

方法

推导队列包括326例IPF患者。根据Cox回归模型得出的系数调整变量的权重。将总分分配到疾病的三个阶段,以使每个阶段纳入的患者数量合适。在另一个由117例IPF患者组成的日本队列和一个韩国IPF患者全国队列中分析改良模型的有效性。

结果

在推导队列中,使用改良GAP模型对IPF各阶段的预测生存率有显著差异(对数秩检验:I期与II期,p < 0.001;II期与III期,p < 0.001)。根据Harrell's C指数,模型性能有所改善(三年时:原始GAP模型为0.696,改良模型为0.738)。改良模型的性能在日本验证队列和韩国全国队列中得到了验证。

结论

我们对原始GAP模型的改良在东亚IPF患者群体中表现出更好的性能。

相似文献

1
A modified GAP model for East-Asian populations with idiopathic pulmonary fibrosis.一种针对东亚特发性肺纤维化人群的改良GAP模型。
Respir Investig. 2020 Sep;58(5):395-402. doi: 10.1016/j.resinv.2020.04.001. Epub 2020 Jul 24.
2
Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study.使用GAP评分预测特发性肺纤维化患者的生存率:一项全国性队列研究。
Respir Res. 2016 Oct 18;17(1):131. doi: 10.1186/s12931-016-0454-0.
3
Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline.特发性肺纤维化:预测未来肺功能下降的性别-年龄-生理指数分期
Chest. 2016 Feb;149(2):491-498. doi: 10.1378/chest.15-0530. Epub 2016 Jan 12.
4
A multidimensional index and staging system for idiopathic pulmonary fibrosis.特发性肺纤维化的多维指数和分期系统。
Ann Intern Med. 2012 May 15;156(10):684-91. doi: 10.7326/0003-4819-156-10-201205150-00004.
5
Comparisons of Prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study.使用间隙模型比较手术诊断与临床诊断的特发性肺纤维化的预后:一项韩国全国队列研究。
Medicine (Baltimore). 2016 Mar;95(11):e3105. doi: 10.1097/MD.0000000000003105.
6
Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.中东地区特发性肺纤维化患者的临床及功能转归
Clin Respir J. 2008 Oct;2(4):220-6. doi: 10.1111/j.1752-699X.2008.00070.x.
7
Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis.GAP评分在韩国特发性肺纤维化患者中的验证
Chest. 2015 Feb;147(2):430-437. doi: 10.1378/chest.14-0453.
8
Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.特发性间质性肺炎未分类急性加重:与特发性肺纤维化的比较。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620935774. doi: 10.1177/1753466620935774.
9
Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.基质金属蛋白酶-7在特发性肺纤维化中预后价值的验证
Respirology. 2017 Apr;22(3):486-493. doi: 10.1111/resp.12920. Epub 2016 Oct 19.
10
Disease severity staging system for idiopathic pulmonary fibrosis in Japan.日本特发性肺纤维化疾病严重程度分期系统。
Respirology. 2017 Nov;22(8):1609-1614. doi: 10.1111/resp.13138. Epub 2017 Aug 8.

引用本文的文献

1
Impact of GAP score on surgical prognosis of non-small-cell lung cancer with usual interstitial pneumonia.GAP评分对合并普通型间质性肺炎的非小细胞肺癌手术预后的影响
Gen Thorac Cardiovasc Surg. 2024 Oct 23. doi: 10.1007/s11748-024-02096-w.
2
Modified blood cell GAP model as a prognostic biomarker in idiopathic pulmonary fibrosis.改良血细胞GAP模型作为特发性肺纤维化的预后生物标志物
ERJ Open Res. 2024 Jul 29;10(4). doi: 10.1183/23120541.00666-2023. eCollection 2024 Jul.
3
Prognostic significance of antifibrotic agents in idiopathic pulmonary fibrosis after initiation of long-term oxygen therapy.
长期氧疗开始后抗纤维化药物在特发性肺纤维化中的预后意义
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26;41(1):e2024002. doi: 10.36141/svdld.v41i1.15264.
4
Multidisciplinary-derived clinical score for accurate prediction of long-term mortality in fibrotic lung disease patients.多学科衍生临床评分准确预测肺纤维化疾病患者的长期死亡率。
Eur J Med Res. 2024 Jan 20;29(1):69. doi: 10.1186/s40001-024-01644-7.
5
Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease.血清KL-6作为纤维化间质性肺疾病任何阶段病情进展的生物标志物。
J Clin Med. 2023 Feb 1;12(3):1173. doi: 10.3390/jcm12031173.
6
Prognostic value of tripartite motif (TRIM) family gene signature from bronchoalveolar lavage cells in idiopathic pulmonary fibrosis.支气管肺泡灌洗液中三联基序(TRIM)家族基因特征对特发性肺纤维化的预后价值。
BMC Pulm Med. 2022 Dec 6;22(1):467. doi: 10.1186/s12890-022-02269-4.
7
Lung cancer surgery after COVID-19 infection in a patient with severe interstitial pneumonia and restrictive ventilatory impairment.一名患有严重间质性肺炎和限制性通气功能障碍的患者在感染 COVID-19 后的肺癌手术
Surg Case Rep. 2022 Sep 21;8(1):173. doi: 10.1186/s40792-022-01531-5.
8
Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study.特发性肺纤维化临床预后模型的偏倚与报告质量:一项横断面研究
Risk Manag Healthc Policy. 2022 Jun 8;15:1189-1201. doi: 10.2147/RMHP.S357606. eCollection 2022.
9
Radiological and Physiological Predictors of IPF Mortality.特发性肺纤维化死亡率的放射学和生理学预测因子。
Medicina (Kaunas). 2021 Oct 18;57(10):1121. doi: 10.3390/medicina57101121.